Literature DB >> 1313509

Multistage carcinogenesis: population-based model for colon cancer.

S H Moolgavkar1, E G Luebeck.   

Abstract

BACKGROUND: Recent laboratory work and previous models suggest that multiple mutations are associated with the development of colon cancer. PURPOSE AND METHODS: To estimate the number of mutations required for colon carcinogenesis, we used likelihood analysis to obtain the best fit between mathematical models postulating different numbers of rate-limiting events and data on incidence rates of colon cancer in two human populations--the general population of Birmingham, England, from 1968 to 1972 and patients with familial adenomatous polyposis (FAP) diagnosed at Saint Mark's Hospital, London, England, between 1925 and 1965. The Armitage-Doll model and two- and three-mutation models that explicitly incorporated cell proliferation kinetics were used.
RESULTS: When cell kinetics were considered, models postulating either two or three rate-limiting events described the incidence rates of colon cancer equally well in both human populations. A comparison of the incidence rate of colon cancer in the general population with that in patients with polyposis suggests that a mutation at the FAP gene locus is not one of the rate-limiting events in colon carcinogenesis.
CONCLUSIONS: Compared with the two-mutation model, the three-mutation model was more consistent with the number of mutations reported to date in colon cancer and with mutation rates measured in the laboratory. IMPLICATIONS: A mutation at the FAP locus may not be a rate-limiting step but may act indirectly by stimulating the proliferation of stem cells. Thus, the development of colon cancer in patients with FAP does not appear to fit the retinoblastoma paradigm.

Entities:  

Mesh:

Year:  1992        PMID: 1313509     DOI: 10.1093/jnci/84.8.610

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  31 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

3.  Age-incidence relationships and time trends in cervical cancer in Sweden.

Authors:  K Hemminki; X Li; P Mutanen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Accumulation of driver and passenger mutations during tumor progression.

Authors:  Ivana Bozic; Tibor Antal; Hisashi Ohtsuki; Hannah Carter; Dewey Kim; Sining Chen; Rachel Karchin; Kenneth W Kinzler; Bert Vogelstein; Martin A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

5.  Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach.

Authors:  Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Math Biosci       Date:  2008-02-26       Impact factor: 2.144

6.  Multistage carcinogenesis and the incidence of colorectal cancer.

Authors:  E Georg Luebeck; Suresh H Moolgavkar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

Review 7.  The preneoplastic phenotype in murine mammary tumorigenesis.

Authors:  D Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 8.  Cancer models, genomic instability and somatic cellular Darwinian evolution.

Authors:  Mark P Little
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

Review 9.  Towards a multiscale model of colorectal cancer.

Authors:  Ingeborg M M van Leeuwen; Carina M Edwards; Mohammad Ilyas; Helen M Byrne
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

10.  Parallel routes of human carcinoma development: implications of the age-specific incidence data.

Authors:  James P Brody
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.